Tags

Type your tag names separated by a space and hit enter

In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Fertil Steril. 2009 Feb; 91(2):377-82.FS

Abstract

OBJECTIVES

To compare the results of IVF cycles after coasting in patients treated with a GnRH antagonist or GnRH agonist protocol.

DESIGN

A retrospective case-control study.

SETTING

Infertility unit in a university-affiliated tertiary medical center.

PATIENT(S)

The study group included all women less than 38 years old attending the IVF unit from 2000 to 2006 in whom coasting was used. Data on E(2) levels before and after coasting, duration of coasting, number of oocytes retrieved and fertilized, embryo quality, moderate-severe ovarian hyperstimulation syndrome (OHSS), and pregnancy were collected from the files and compared between GnRH agonist (n = 329) and GnRH antagonist (n = 45) cycles.

INTERVENTION(S)

None.

MAIN OUTCOME MEASURE(S)

Number of retrieved oocytes and pregnancy rates.

RESULT(S)

There were no between-group differences in cycle parameters. In the antagonist group, there was no need for more than 2 days of coasting. There was a significant decrease in the number of retrieved oocytes even in short periods of coasting in the antagonist group but not in the agonist group. On the day of hCG administration, E(2) levels dropped to a lower level in the antagonist cycles. The OHSS rate after coasting was 4.6% in the agonist group and 4.4% in the antagonist group. Corresponding pregnancy rates after coasting were 27.4% and 24.4%.

CONCLUSION(S)

The same criteria for coasting can be applied in GnRH agonist as in GnRH antagonist cycles, with a similar IVF result.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel. j_farhi@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

18321490

Citation

Farhi, Jacob, et al. "In Vitro Fertilization Cycle Outcome After Coasting in Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols." Fertility and Sterility, vol. 91, no. 2, 2009, pp. 377-82.
Farhi J, Ben-Haroush A, Lande Y, et al. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols. Fertil Steril. 2009;91(2):377-82.
Farhi, J., Ben-Haroush, A., Lande, Y., Sapir, O., Pinkas, H., & Fisch, B. (2009). In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols. Fertility and Sterility, 91(2), 377-82. https://doi.org/10.1016/j.fertnstert.2007.11.086
Farhi J, et al. In Vitro Fertilization Cycle Outcome After Coasting in Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols. Fertil Steril. 2009;91(2):377-82. PubMed PMID: 18321490.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols. AU - Farhi,Jacob, AU - Ben-Haroush,Avi, AU - Lande,Yehezkel, AU - Sapir,Onit, AU - Pinkas,Haim, AU - Fisch,Benjamin, Y1 - 2008/03/05/ PY - 2007/09/03/received PY - 2007/11/28/revised PY - 2007/11/28/accepted PY - 2008/3/7/pubmed PY - 2009/2/21/medline PY - 2008/3/7/entrez SP - 377 EP - 82 JF - Fertility and sterility JO - Fertil Steril VL - 91 IS - 2 N2 - OBJECTIVES: To compare the results of IVF cycles after coasting in patients treated with a GnRH antagonist or GnRH agonist protocol. DESIGN: A retrospective case-control study. SETTING: Infertility unit in a university-affiliated tertiary medical center. PATIENT(S): The study group included all women less than 38 years old attending the IVF unit from 2000 to 2006 in whom coasting was used. Data on E(2) levels before and after coasting, duration of coasting, number of oocytes retrieved and fertilized, embryo quality, moderate-severe ovarian hyperstimulation syndrome (OHSS), and pregnancy were collected from the files and compared between GnRH agonist (n = 329) and GnRH antagonist (n = 45) cycles. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Number of retrieved oocytes and pregnancy rates. RESULT(S): There were no between-group differences in cycle parameters. In the antagonist group, there was no need for more than 2 days of coasting. There was a significant decrease in the number of retrieved oocytes even in short periods of coasting in the antagonist group but not in the agonist group. On the day of hCG administration, E(2) levels dropped to a lower level in the antagonist cycles. The OHSS rate after coasting was 4.6% in the agonist group and 4.4% in the antagonist group. Corresponding pregnancy rates after coasting were 27.4% and 24.4%. CONCLUSION(S): The same criteria for coasting can be applied in GnRH agonist as in GnRH antagonist cycles, with a similar IVF result. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/18321490/In_vitro_fertilization_cycle_outcome_after_coasting_in_gonadotropin_releasing_hormone__GnRH__agonist_versus_GnRH_antagonist_protocols_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(07)04150-7 DB - PRIME DP - Unbound Medicine ER -